CourseNURS-6630N
Test Week 11 Final Exam
• Question 1
A patient diagnosed with obsessive compulsive disorder has been
taking a high-dose SSRI and is participating in therapy twice a week.
He reports an inability to carry out responsibilities due to consistent
interferences of his obsessions and compulsions. The PMHNP knows
that the next step would be which of the following?
Answer: Decrease his SSRI and add an MAOI.
• Question 2
Which statement best describes a pharmacological approach to
treating patients for impulsive aggression?
Answer: Atypical antipsychotics can increase subcortical
dopaminergic stimulation.
• Question 3
1 out of 1 points
, The PMHNP evaluates a patient presenting with symptoms of
dementia. Before the PMHNP considers treatment options, the
patient must be assessed for other possible causes of dementia.
Which of the following answers addresses both possible other
causes of dementia and a rational treatment option for
Dementia?
Selected B.
Answer: Possible other causes: hypothyroidism, adrenal
insufficiency, hyperparathyroidism
Possible treatment option: donepezil
• Question 4
1 out of 1
points An 80-year-old female patient diagnosed with Stage II
Alzheimer’s has a history of irritable bowel syndrome. Which
cholinergic drug may be the best choice for treatment given the
patient’s gastrointestinal problems?
Selected Answer: A.
Donepezil (Aricept)
• Question 5
1 out of 1
points The PMHNP is teaching parents about their child’s new
prescription for Ritalin. What will the PMHNP include in the teaching?
Answer: There will be continued effects into the evening.
• Question 6
, 1 out of 1
points The PMHNP prescribes gabapentin (Neurontin) for a patient’s
chronic pain. How does the PMHNP anticipate the drug to work?
Selected A.
Answer: It will bind to the alpha-2-delta ligand subunit of
voltage-sensitive calcium channels.
• Question 7
1 out of 1
points An opioid-naive patient is taking MS Contin (morphine sulfate)
to treat his pain that is secondary to cancer. Under what
circumstances would the PMHNP order naloxone (Narcan) IM/SQ?
Selected D.
Answer: The patient’s vital signs are 98.4F temp, 88 pulse,
104/62 blood pressure, and 8 respirations.
• Question 8
1 out of 1
points A patient is prescribed D-methylphenidate, 10-mg extended-
release capsules. What should the PMHNP include when discussing
the side effects with the patient?
Selected Answer: C.
The medication can affect your blood
pressure.
• Question 9
1 out of 1 points
Test Week 11 Final Exam
• Question 1
A patient diagnosed with obsessive compulsive disorder has been
taking a high-dose SSRI and is participating in therapy twice a week.
He reports an inability to carry out responsibilities due to consistent
interferences of his obsessions and compulsions. The PMHNP knows
that the next step would be which of the following?
Answer: Decrease his SSRI and add an MAOI.
• Question 2
Which statement best describes a pharmacological approach to
treating patients for impulsive aggression?
Answer: Atypical antipsychotics can increase subcortical
dopaminergic stimulation.
• Question 3
1 out of 1 points
, The PMHNP evaluates a patient presenting with symptoms of
dementia. Before the PMHNP considers treatment options, the
patient must be assessed for other possible causes of dementia.
Which of the following answers addresses both possible other
causes of dementia and a rational treatment option for
Dementia?
Selected B.
Answer: Possible other causes: hypothyroidism, adrenal
insufficiency, hyperparathyroidism
Possible treatment option: donepezil
• Question 4
1 out of 1
points An 80-year-old female patient diagnosed with Stage II
Alzheimer’s has a history of irritable bowel syndrome. Which
cholinergic drug may be the best choice for treatment given the
patient’s gastrointestinal problems?
Selected Answer: A.
Donepezil (Aricept)
• Question 5
1 out of 1
points The PMHNP is teaching parents about their child’s new
prescription for Ritalin. What will the PMHNP include in the teaching?
Answer: There will be continued effects into the evening.
• Question 6
, 1 out of 1
points The PMHNP prescribes gabapentin (Neurontin) for a patient’s
chronic pain. How does the PMHNP anticipate the drug to work?
Selected A.
Answer: It will bind to the alpha-2-delta ligand subunit of
voltage-sensitive calcium channels.
• Question 7
1 out of 1
points An opioid-naive patient is taking MS Contin (morphine sulfate)
to treat his pain that is secondary to cancer. Under what
circumstances would the PMHNP order naloxone (Narcan) IM/SQ?
Selected D.
Answer: The patient’s vital signs are 98.4F temp, 88 pulse,
104/62 blood pressure, and 8 respirations.
• Question 8
1 out of 1
points A patient is prescribed D-methylphenidate, 10-mg extended-
release capsules. What should the PMHNP include when discussing
the side effects with the patient?
Selected Answer: C.
The medication can affect your blood
pressure.
• Question 9
1 out of 1 points
